Feasibility Study of Oral Ketamine Versus Placebo for the Treatment of Anxiety in Patients With Pancreatic Cancer
EARLY_PHASE1
20
about 4.2 years
18+
1 site in CA
About this study
This trial is testing whether oral ketamine or a placebo can help reduce anxiety in people with pancreatic cancer. The goal is to see if it's possible to enroll enough patients and have them follow the treatment plan. Researchers will also look at safety, tolerability, and how ketamine/placebo affects anxiety symptoms and other health measures.
Based on ClinicalTrials.gov records.
What participants do
- 1.Take Ketamine
- 2.Take Placebo
Participation effort
Estimated from trial records. Details can vary by site.
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
ketamine (NMDA receptor antagonist; induces dissociative anesthesia and analgesia)
Secondary: To investigate the safety of oral ketamine in patients with pancreatic cancer and anxiety, which will be assessed by the number of adverse events related to study treatment per CTCAE v.5., To investigate the tolerability of oral ketamine in patients with pancreatic cancer and anxiety, which will be measured by patient-reported Ketamine Adverse Symptom Checklist and Impact scores.
Psychiatry / Mental Health, Oncology